BACKGROUND: Temporal trends in incidence and prevalence of Crohn's disease (CD) and ulcerative colitis (UC) in the United States have been reported only in regional populations. The Veterans Affairs (VA) health care system encompasses a national network of clinical care facilities. The aim of this study was to identify temporal trends in the incidence and prevalence of CD and UC among VA users using national VA data sets. METHODS: Veterans with CD and UC were identified during fiscal years 1998 to 2009 in the national VA outpatient and inpatient files. Incident and prevalent cases were identified by diagnosis code, and age-standardized and gender-standardized annual prevalence and incidence rates were estimated using the VA 1998 population as the standard population. RESULTS: The total of unique incident cases were 16,842 and 26,272 for CD and UC, respectively; 94% were men. The average annual age-standardized and gender-standardized incidence rate of CD was 33 per 100,000 VA users (range, 27-40), whereas the average for UC was 50 per 100,000 VA users (range, 36-65). In 2009, the age-standardized and gender-standardized point prevalence rate of CD was 287 per 100,000 VA users, whereas the point prevalence of UC was 413 per 100,000 VA users. CONCLUSIONS: Prevalence of CD and UC increased 2-fold to 3-fold among VA users between 1998 and 2009. The incidence of UC decreased among VA users from 1998 to 2004 but has remained stable from 2005 to 2009. The incidence of CD has remained stable during the observed time period.
BACKGROUND: Temporal trends in incidence and prevalence of Crohn's disease (CD) and ulcerative colitis (UC) in the United States have been reported only in regional populations. The Veterans Affairs (VA) health care system encompasses a national network of clinical care facilities. The aim of this study was to identify temporal trends in the incidence and prevalence of CD and UC among VA users using national VA data sets. METHODS: Veterans with CD and UC were identified during fiscal years 1998 to 2009 in the national VA outpatient and inpatient files. Incident and prevalent cases were identified by diagnosis code, and age-standardized and gender-standardized annual prevalence and incidence rates were estimated using the VA 1998 population as the standard population. RESULTS: The total of unique incident cases were 16,842 and 26,272 for CD and UC, respectively; 94% were men. The average annual age-standardized and gender-standardized incidence rate of CD was 33 per 100,000 VA users (range, 27-40), whereas the average for UC was 50 per 100,000 VA users (range, 36-65). In 2009, the age-standardized and gender-standardized point prevalence rate of CD was 287 per 100,000 VA users, whereas the point prevalence of UC was 413 per 100,000 VA users. CONCLUSIONS: Prevalence of CD and UC increased 2-fold to 3-fold among VA users between 1998 and 2009. The incidence of UC decreased among VA users from 1998 to 2004 but has remained stable from 2005 to 2009. The incidence of CD has remained stable during the observed time period.
Authors: Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard Journal: Am J Gastroenterol Date: 2006-07 Impact factor: 10.864
Authors: Conor G Loftus; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; L Joseph Melton; William J Sandborn Journal: Inflamm Bowel Dis Date: 2007-03 Impact factor: 5.325
Authors: Lisa J Herrinton; Liyan Liu; Jennifer Elston Lafata; James E Allison; Susan E Andrade; Eli J Korner; K Arnold Chan; Richard Platt; Deborah Hiatt; Siobhán O'Connor Journal: Inflamm Bowel Dis Date: 2007-04 Impact factor: 5.325
Authors: N Morita; S Toki; T Hirohashi; T Minoda; K Ogawa; S Kono; A Tamakoshi; Y Ohno; T Sawada; T Muto Journal: J Gastroenterol Date: 1995-11 Impact factor: 7.527
Authors: Jason K Hou; Jennifer R Kramer; Peter Richardson; Minghua Mei; Hashem B El-Serag Journal: Inflamm Bowel Dis Date: 2011-08-29 Impact factor: 5.325
Authors: Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion Journal: J Pediatr Date: 2003-10 Impact factor: 4.406
Authors: Michael D Kappelman; Sheryl L Rifas-Shiman; Ken Kleinman; Dan Ollendorf; Athos Bousvaros; Richard J Grand; Jonathan A Finkelstein Journal: Clin Gastroenterol Hepatol Date: 2007-09-29 Impact factor: 11.382
Authors: Elyse R Thakur; Shubhada Sansgiry; Jennifer R Kramer; Akbar K Waljee; Jill K Gaidos; Linda A Feagins; Shail M Govani; Lilian Dindo; Hashem B El-Serag; Jason K Hou Journal: Inflamm Bowel Dis Date: 2020-08-20 Impact factor: 5.325
Authors: Jason K Hou; Mimi Tan; Ryan W Stidham; John Colozzi; Devon Adams; Hashem El-Serag; Akbar K Waljee Journal: Dig Dis Sci Date: 2014-05-10 Impact factor: 3.199
Authors: Jesse J Salk; Aasthaa Bansal; Lisa A Lai; David A Crispin; Cigdem H Ussakli; Marshall S Horwitz; Mary P Bronner; Teresa A Brentnall; Lawrence A Loeb; Peter S Rabinovitch; Rosa Ana Risques Journal: Inflamm Bowel Dis Date: 2013-11 Impact factor: 5.325
Authors: Yasamin Farbod; Jelena Popov; David Armstrong; Smita Halder; John K Marshall; Frances Tse; Maria Ines Pinto-Sanchez; Paul Moayyedi; Usha Chauhan Journal: J Can Assoc Gastroenterol Date: 2021-05-19
Authors: Salva N Balbale; Lishan Cao; Itishree Trivedi; Jonah J Stulberg; Katie J Suda; Walid F Gellad; Charlesnika T Evans; Bruce L Lambert; Laurie A Keefer; Neil Jordan Journal: Mil Med Date: 2021-08-28 Impact factor: 1.563